Sue Ellen Masty
Sue Ellen Masty is a retired secondary social studies teacher and was diagnosed with stage I infiltrating ductal carcinoma of the left breast in late October 2014. The tumor was discovered as a result of her yearly mammogram and was undetectable with self-examination. She had a lumpectomy, Oncotype DX testing, chemotherapy, radiation therapy, and is currently taking aromatase inhibitors.
Sue Ellen then joined the Surveillance Markers of Utility for Recurrence After (Neo)adjuvant Therapy for Breast Cancer (SURMOUNT) study and the Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer trail, both being held at Penn Medicine’s Abramson Cancer Center in Philadelphia.
As a woman in her 60's, Sue was not shocked by the original diagnosis. She has a strong family history of cancer: her maternal aunt and grandmother both passed away of breast cancer, her sister of colon rectal cancer, and her father of leukemia. She strongly advocates that women take responsibility for their wellness by pursuing all courses of action available to them, and she is grateful to the medical professionals who have provided excellent care along the way.